US Patent Issued to Jiangsu Hengrui Pharmaceuticals on Feb. 18 for "Fused imidazole derivative, preparation method therefor, and medical use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,499, issued on Feb. 18, was assigned to Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Jiangsu, China).

"Fused imidazole derivative, preparation method therefor, and medical use thereof" was invented by Fanglong Yang (Shanghai), Ling Zhang (Shanghai), Liangliang Zheng (Shanghai), Feng He (Shanghai) and Weikang Tao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are fused imidazole derivatives, preparation methods therefor and medical uses thereof. Specifically, the present disclosure relates to a fused imidazole derivative as shown in general formula (IM), a preparation method therefor, a pharmaceutical composition containing the deriv...